Pediatric restrictive cardiomyopathy associated with a mutation in β-myosin heavy chain

Most children do not have a known cause of cardiomyopathy which limits the potential for disease‐specific therapies. Of the different phenotypic presentations of cardiomyopathy, the restrictive form carries the poorest prognosis and has the lowest rate of identification of etiology. We present the f...

Full description

Saved in:
Bibliographic Details
Published inClinical genetics Vol. 73; no. 2; pp. 165 - 170
Main Authors Ware, SM, Quinn, ME, Ballard, ET, Miller, E, Uzark, K, Spicer, RL
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.02.2008
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Most children do not have a known cause of cardiomyopathy which limits the potential for disease‐specific therapies. Of the different phenotypic presentations of cardiomyopathy, the restrictive form carries the poorest prognosis and has the lowest rate of identification of etiology. We present the first description of a β‐myosin heavy chain gene mutation in an infant with restrictive cardiomyopathy requiring cardiac transplantation. As demonstrated by three‐dimensional protein structure modeling, the missense mutation is in a highly conserved amino acid at the critical binding region for the essential light chain. This case emphasizes that mutations in sarcomeric proteins, which are known to cause hypertrophic cardiomyopathy in adults, may be associated with the development of restrictive physiology in childhood. Identification of the genetic basis of pediatric cardiomyopathy has important implications for management and genetic counseling.
Bibliography:istex:19D8175067327BA0F8E9610E8EBC705EB60080B9
ArticleID:CGE939
ark:/67375/WNG-NC795LK1-Z
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0009-9163
1399-0004
DOI:10.1111/j.1399-0004.2007.00939.x